Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « MeshFr.i » - entrée « Essais cliniques comme sujet »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Essais cliniques adaptatifs comme sujet < Essais cliniques comme sujet < Essais cliniques contrôlés comme sujet  Facettes :

List of bibliographic references indexed by Essais cliniques comme sujet

Number of relevant bibliographic references: 126.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000029 (2021) Maurizio Koch[2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.]
000044 (2021) Jason D. Goldman [États-Unis] ; George Diaz [États-Unis] ; Walter J. Urba [États-Unis]Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000045 (2021) Mudit Agarwal [Inde] ; Piyush Ranjan [Inde] ; Ankit Mittal [Inde] ; Upendra Baitha [Inde]Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
000077 (2021) Muhammad Sani Ismaila [Trinité-et-Tobago] ; Faruku Bande [Nigeria] ; Aminu Ishaka [Nigeria] ; Aminatu Abubakar Sani [Nigeria] ; Karla Georges [Trinité-et-Tobago]Therapeutic options for COVID-19: a quick review.
000084 (2021) Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis]The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.
000093 (2021) Derek Shyr [États-Unis] ; Yu Shyr [États-Unis]The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic.
000105 (2021) Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Mohammad Ali N. Maktabi [Liban] ; Rami Mahfouz [Liban]The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
000150 (2021) Philippe Gautret [France] ; Stéphane Honoré [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000166 (2021) Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie]SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
000168 (2021) Peyman Kheirandish Zarandi [Iran] ; Mohammad Reza Zinatizadeh [Iran] ; Maryam Zinatizadeh [Iran] ; Mohammad Hadi Yousefi [Iran] ; Nima Rezaei [Iran]SARS-CoV-2: From the pathogenesis to potential anti-viral treatments.
000190 (2021) Dingzhong Li [République populaire de Chine] ; Jianbing Hu [République populaire de Chine] ; Dian Li [République populaire de Chine] ; Weijun Yang [République populaire de Chine] ; Shuang-Feng Yin [République populaire de Chine] ; Renhua Qiu [République populaire de Chine]Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19.
000218 (2021) Marcelo Rodrigues Dos Santos [Brésil]Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
000219 (2021) Fiona Marra [Royaume-Uni] ; Elise J. Smolders [Pays-Bas] ; Omar El-Sherif [Royaume-Uni] ; Alison Boyle [Royaume-Uni] ; Katherine Davidson [Royaume-Uni] ; Andrew J. Sommerville [Royaume-Uni] ; Catia Marzolini [Royaume-Uni, Suisse] ; Marco Siccardi [Royaume-Uni] ; David Burger [Pays-Bas] ; Sara Gibbons [Royaume-Uni] ; Saye Khoo [Royaume-Uni] ; David Back [Royaume-Uni]Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
000294 (2021) Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde]One year update on the COVID-19 pandemic: Where are we now?
000338 (2021) Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni]Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
000345 (2021) Claudia Musial [Pologne] ; Magdalena Gorska-Ponikowska [Pologne]Medical progress: Stem cells as a new therapeutic strategy for COVID-19.
000352 (2021) Nicolas De Schryver [Belgique] ; Nicolas Serck [Belgique] ; Marco Vinetti [Belgique] ; Ludovic Gérard [Belgique]Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.
000356 (2021) Mohamed O. Saad [Qatar]Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000368 (2021) Sophie Juul [Danemark] ; Emil Eik Nielsen [Danemark] ; Joshua Feinberg [Danemark] ; Faiza Siddiqui [Danemark] ; Caroline Kamp J Rgensen [Danemark] ; Emily Barot [Danemark] ; Johan Holgersson [Suède] ; Niklas Nielsen [Suède] ; Peter Bentzer [Suède] ; Areti Angeliki Veroniki [Grèce, Canada] ; Lehana Thabane [Canada] ; Fanlong Bu [République populaire de Chine] ; Sarah Klingenberg [Danemark] ; Christian Gluud [Danemark] ; Janus Christian Jakobsen [Danemark]Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
000369 (2021) Philippe Colson [France] ; Bernard La Scola [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Didier Raoult [France]Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
000373 (2021) Irina Panovska-Stavridis ; Nevenka Ridova ; Tatjana Stojanoska ; Ilir Demiri ; Milena Stevanovic ; Simona Stojanovska ; Tara Ristevska ; Aleksandar Dimkovski ; Venko Filipce ; Aleksandar Dimovski ; Aleksandra GrozdanovaInsight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Essais cliniques comme sujet" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Essais cliniques comme sujet" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Essais cliniques comme sujet
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021